Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study

Jacob P. Laubach, Fredrik Schjesvold, Mário Mariz, Meletios A. Dimopoulos, Ewa Lech-Maranda, Ivan Spicka, Vania T.M. Hungria, Tatiana Shelekhova, Andre Abdo, Lutz Jacobasch, Chantana Polprasert, Roman Hájek, Árpád Illés, Tomasz Wróbel, Anna Sureda, Meral Beksac, Iara Z. Gonçalves, Joan Bladé, S. Vincent Rajkumar, Ajai ChariSagar Lonial, Andrew Spencer, Pierre Maison-Blanche, Philippe Moreau, Jesus F. San-Miguel, Paul G. Richardson

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences